Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neurology. 2006 Oct 10;67(7):1275-8.

Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID.

Author information

  • 1Department of Neurology, University of Pennsylvania Medical Center, Philadelphia, PA, USA. kasner@mail.med.upenn.edu

Abstract

The WASID trial showed no advantage of warfarin over aspirin for preventing the primary endpoint of ischemic stroke, brain hemorrhage, or vascular death. In analyses of selected subgroups, there was no definite benefit from warfarin. Warfarin reduced the risk of the primary endpoint among patients with basilar artery stenosis, but there was no reduction in stroke in the basilar artery territory or benefit for vertebral artery stenosis or posterior circulation disease in general.

PMID:
17030766
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk